SUTRO BIOPHARMA, INC.

STRO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015
Assets
Cash & Equivalents $22.0M $11.6M
Accounts Receivable $1.6M
Inventory
Total Current Assets $25.6M
Property, Plant & Equipment $14.0M
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $40.8M
Liabilities
Accounts Payable $2.9M
Total Current Liabilities $32.0M
Long-Term Debt
Total Liabilities $47.3M
Stockholders' Equity
Retained Earnings $-115.0M
Total Stockholders' Equity $-109.0M $-90.9M $-93.9M
← Newer Page 2 of 2 Older →